Immunotherapy Options for Breast Cancer
Trial results raise questions about two immune checkpoint inhibitors approved for treatment of some people with advanced breast cancer.
Home > Patients, Caregivers, and Advocates > Research > Immunotherapy Options for Breast Cancer
Trial results raise questions about two immune checkpoint inhibitors approved for treatment of some people with advanced breast cancer.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now